Home/News/Details

EU Extends Chemical Regulations to Embrace DMAC and NEP under REACH Annex XVII

Aug 26, 2024
EU
REACH
Favorites
Share
Unlock exclusive content and benefits? Sign up for free today!

On July 30, 2024, the European Commission submitted Notification G/TBT/N/EU/1079 to the WTO, announcing updates to Annex XVII of the REACH Regulation with new restrictions on N,N-dimethylacetamide (DMAC) and N-ethylpyrrolidone (NEP). These changes are set to take effect 20 days after publication in the EU Official Journal.

Annex XVII restricts the use of certain hazardous chemicals in the EU market. The inclusion of DMAC and NEP will subject these chemicals to strict regulatory oversight, ensuring that all products containing them, whether produced or sold in the EU, meet stringent safety standards to protect health and the environment.

The specific updates are as follows.

Substance’ name

CAS NUm./

EC Num.
Restrictive measure
Dimethylacetamide (DMAC)

127-19-5

204-826-4
  1. Shall not be placed on the market as a substance on its own, as a constituent of other substances, or in mixtures in a concentration equal to or greater than 0,3 % after [date] unless manufacturers, importers and downstream users have included in the chemical safety reports and safety data sheets, Derived No-Effect Levels (DNELs) relating to exposure of workers of 13 mg/m3 for long-term exposure by inhalation and 0,53 mg/kg/day for longterm dermal exposure.
  2. Shall not be manufactured, or used, as a substance on its own, as a constituent of other substances, or in mixtures in a concentration equal to or greater than 0,3 % after [date as in paragraph 1] unless manufacturers and downstream users take the appropriate risk management measures and take the appropriate operational conditions to ensure that exposure of workers is below both the DNELs specified in paragraph 1.
1-ethyl-2-pyrrolidinon (NEP)

2687-91-4

220-250-6
  1. Shall not be placed on the market as a substance on its own, as a constituent of other substances, or in mixtures in a concentration equal to or greater than 0,3 % after [date] unless manufacturers, importers and downstream users have included in the chemical safety reports and safety data sheets, Derived No-Effect Levels (DNELs) relating to exposure of workers of 4,0 mg/m3 for long-term and 4,6 for acute exposures by inhalation and 2,4 mg/kg/day for long-term dermal exposure.
  2. Shall not be manufactured, or used, as a substance on its own, as a constituent of other substances, or in mixtures in a concentration equal to or greater than 0,3 % after [date as in paragraph 1] unless manufacturers and downstream users take the appropriate risk management measures and take the appropriate operational conditions to ensure that exposure of workers is below both the DNELs specified in paragraph 1.
 
Further Information

ECHA

ChemRadar Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: ChemRadar" on this website are copyrighted by ChemRadar. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: ChemRadar" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: ChemRadar" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on ChemRadar raises copyright or other related issues, please contact us within two weeks.

Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
Feedbacks
Service Hotline